Back to Search
Start Over
Phase 1 dose escalation of SYS6002 (CRB-701), a next-generation nectin-4 targeting antibody drug conjugate (ADC).
- Source :
- Journal of Clinical Oncology; 2024 Supplement 4, Vol. 42, p622-622, 193p
- Publication Year :
- 2024
Details
- Language :
- English
- ISSN :
- 0732183X
- Volume :
- 42
- Database :
- Supplemental Index
- Journal :
- Journal of Clinical Oncology
- Publication Type :
- Academic Journal
- Accession number :
- 175074278
- Full Text :
- https://doi.org/10.1200/JCO.2024.42.4_suppl.622